Recent studies have shown that the PPAR-γ is a key inhibitor of colitis, by reducing NF-κB transcriptional activity25,47–49, or can interact with active p65 and facilitate its nuclear export in response to bacterial stimuli, which subsequently inhibits NF-κB activation50. This evidence concerns the gene PPARG and colitis.